Chrysalis Biosciences:
The Chrysalis Biosciences chemical plant in Illinois is a prominent facility specializing in the production and development of various biochemical products used in pharmaceuticals, agriculture, and industrial applications. The plant employs approximately 250 workers who are involved in diverse roles ranging from research and development to production and quality control. The facility handles a wide array of chemicals, including solvents, reagents, and active pharmaceutical ingredients (APIs). Notably, they work with substances such as benzene, toluene, formaldehyde, and various organic compounds that are essential in synthesizing complex biochemical products.
Workers at Chrysalis Biosciences are regularly exposed to these chemicals, which can pose significant health risks if proper safety measures are not adhered to. Benzene and formaldehyde are known carcinogens and can cause leukemia and other forms of cancer with prolonged exposure. Toluene, while less toxic, can still lead to neurological damage, respiratory issues, and skin irritation. Additionally, many organic solvents used in the plant can cause liver and kidney damage, reproductive health issues, and central nervous system effects.
